Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection

Nungruthai Suntronwong,Sitthichai Kanokudom,Chompoonut Auphimai,Thanunrat Thongmee,Suvichada Assawakosri,Preeyaporn Vichaiwattana,Ritthideach Yorsaeng,Thaneeya Duangchinda,Warangkana Chantima,Pattarakul Pakchotanon,Pornjarim Nilyanimit,Donchida Srimuan,Thaksaporn Thatsanathorn,Natthinee Sudhinaraset,Nasamon Wanlapakorn,Yong Poovorawan

DOI: https://doi.org/10.3390/vaccines12020180

2024-02-11

Vaccines

Abstract:Numerous studies have largely focused on short-term immunogenicity in recovered individuals post mRNA vaccination. However, understanding the long-term durability, particularly in inactivated and adenoviral vectored vaccines, remains limited. We evaluated antibody responses, omicron variant neutralization, and IFN-γ responses in 119 previously infected individuals vaccinated with CoronaVac or ChAdOx1 up to six months post-vaccination. Both vaccines elicited robust immune responses in recovered individuals, surpassing those who were infection-naïve, and these persisted above pre-vaccination levels for six months. However, antibody levels declined over time (geometric mean ratio (GMR) = 0.52 for both vaccines). Notably, neutralizing activities against omicron declined faster in ChAdOx1 (GMR = 0.6) compared to CoronaVac recipients (GMR = 1.03). While the first dose of ChAdOx1 adequately induced immune responses in recovered individuals, a second dose demonstrated advantages in omicron variant neutralization and slower decline. Although both vaccines induced T cell responses, the median IFN-γ level at six months returned to pre-vaccination levels. However, more individuals exhibited reactive T cell responses. Extending the interval (13–15 months) between infection and vaccination could enhance antibody levels and broaden neutralization. Together, these findings demonstrate a robust humoral and cellular response that was sustained for at least six months after vaccination, thus guiding optimal vaccination strategies based on prior infection and vaccine platforms.

immunology,medicine, research & experimental

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to understand the long - term dynamic changes in immune responses after inoculation with the inactivated vaccine (CoronaVac) and the adenovirus - vector vaccine (ChAdOx1) in individuals previously infected with SARS - CoV - 2. Specifically, how do the trends and persistence of these immune responses change within up to six months? Specifically, the study focuses on the following points:

1. **Antibody response**: Evaluate the changes in the levels of anti - nucleocapsid protein (anti - N IgG) and anti - receptor - binding domain (anti - RBD IgG) antibodies after vaccination.
2. **Neutralizing activity**: Detect the changes in neutralizing activity against the original strain and variant strains (especially the Omicron variant).
3. **Interferon - γ (IFN - γ) response**: Measure the specific response of T cells to SARS - CoV - 2 antigens.
4. **Effect of time interval**: Explore the effect of the time interval from the initial infection to vaccination (a short interval of 2 - 5 months, a long interval of 13 - 15 months) on the above - mentioned immune responses.

Through these evaluations, the study aims to provide information on the long - term effects of hybrid immunity (a combination of natural infection and vaccine - induced immunity) under different vaccine platforms and how to optimize vaccination strategies to deal with the continuous threat of SARS - CoV - 2 and its variants.